These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 27423327)
21. Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles. Hossaini Nasr S; Rashidijahanabad Z; Ramadan S; Kauffman N; Parameswaran N; Zinn KR; Qian C; Arora R; Agnew D; Huang X Nanoscale; 2020 May; 12(17):9541-9556. PubMed ID: 32314997 [TBL] [Abstract][Full Text] [Related]
22. Inflammation contributes to the atherogenic role of intermittent hypoxia in apolipoprotein-E knock out mice. Arnaud C; Poulain L; Lévy P; Dematteis M Atherosclerosis; 2011 Dec; 219(2):425-31. PubMed ID: 21917260 [TBL] [Abstract][Full Text] [Related]
23. Development of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivatives. Burtea C; Ballet S; Laurent S; Rousseaux O; Dencausse A; Gonzalez W; Port M; Corot C; Vander Elst L; Muller RN Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):e36-48. PubMed ID: 22516067 [TBL] [Abstract][Full Text] [Related]
24. Phospholipid transfer protein destabilizes mouse atherosclerotic plaque. Zhang K; Liu X; Yu Y; Luo T; Wang L; Ge C; Liu X; Song J; Jiang X; Zhang Y; Qin S; Zhang M Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2537-44. PubMed ID: 25324570 [TBL] [Abstract][Full Text] [Related]
25. Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice. Lu Y; Zhang M; Zhao P; Jia M; Liu B; Jia Q; Guo J; Dou L; Li J Mol Med Rep; 2017 Jul; 16(1):647-653. PubMed ID: 28560429 [TBL] [Abstract][Full Text] [Related]
27. Hepcidin destabilizes atherosclerotic plaque via overactivating macrophages after erythrophagocytosis. Li JJ; Meng X; Si HP; Zhang C; Lv HX; Zhao YX; Yang JM; Dong M; Zhang K; Liu SX; Zhao XQ; Gao F; Liu XL; Cui TX; Zhang Y Arterioscler Thromb Vasc Biol; 2012 May; 32(5):1158-66. PubMed ID: 22383698 [TBL] [Abstract][Full Text] [Related]
28. Ticagrelor promotes atherosclerotic plaque stability in a mouse model of advanced atherosclerosis. Preusch MR; Rusnak J; Staudacher K; Mogler C; Uhlmann L; Sievers P; Bea F; Katus HA; Blessing E; Staudacher I Drug Des Devel Ther; 2016; 10():2691-9. PubMed ID: 27616880 [TBL] [Abstract][Full Text] [Related]
29. Caspase-3 Deletion Promotes Necrosis in Atherosclerotic Plaques of ApoE Knockout Mice. Grootaert MO; Schrijvers DM; Hermans M; Van Hoof VO; De Meyer GR; Martinet W Oxid Med Cell Longev; 2016; 2016():3087469. PubMed ID: 27847551 [TBL] [Abstract][Full Text] [Related]
30. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice. Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019 [TBL] [Abstract][Full Text] [Related]
31. Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized low-density lipoprotein-induced apoptosis in macrophages. Xu R; Bi C; Song J; Wang L; Ge C; Liu X; Zhang M Mol Med Rep; 2015 May; 11(5):3229-34. PubMed ID: 25586666 [TBL] [Abstract][Full Text] [Related]
32. [Atorvastatin inhibits the atherosclerotic lesion induced by tumor necrosis factor-like weak inducer of apoptosis in apolipoprotein E deficient mice]. Fernández-Laso V; Sastre C; Egido J; Martín-Ventura JL; Blanco-Colio LM Clin Investig Arterioscler; 2015; 27(1):17-25. PubMed ID: 25027757 [TBL] [Abstract][Full Text] [Related]
33. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques? Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K Mol Imaging; 2014; 13():. PubMed ID: 24757762 [TBL] [Abstract][Full Text] [Related]
34. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice. Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329 [TBL] [Abstract][Full Text] [Related]
35. Vulnerability of atherosclerotic plaques is associated with type I interferon in a murine model of lupus and atherosclerosis. Zhang CY; Qu B; Ye P; Li J; Bao CD Genet Mol Res; 2015 Nov; 14(4):14871-81. PubMed ID: 26600548 [TBL] [Abstract][Full Text] [Related]
37. Pharmacological Treatment with Annexin A1 Reduces Atherosclerotic Plaque Burden in LDLR-/- Mice on Western Type Diet. Kusters DH; Chatrou ML; Willems BA; De Saint-Hubert M; Bauwens M; van der Vorst E; Bena S; Biessen EA; Perretti M; Schurgers LJ; Reutelingsperger CP PLoS One; 2015; 10(6):e0130484. PubMed ID: 26090792 [TBL] [Abstract][Full Text] [Related]
38. Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis. Karunakaran D; Geoffrion M; Wei L; Gan W; Richards L; Shangari P; DeKemp EM; Beanlands RA; Perisic L; Maegdefessel L; Hedin U; Sad S; Guo L; Kolodgie FD; Virmani R; Ruddy T; Rayner KJ Sci Adv; 2016 Jul; 2(7):e1600224. PubMed ID: 27532042 [TBL] [Abstract][Full Text] [Related]
39. Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice. Kumar S; Chen M; Li Y; Wong FH; Thiam CW; Hossain MZ; Poh KK; Hirohata S; Ogawa H; Angeli V; Ge R Sci Rep; 2016 Aug; 6():31130. PubMed ID: 27491335 [TBL] [Abstract][Full Text] [Related]
40. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice. Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]